Literature DB >> 10655407

Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara(-) phenotypes.

C Winstanley1, C A Hart.   

Abstract

Dot blot hybridization and PCR amplification of 14 Ara(+) and 8 Ara(-) Burkholderia pseudomallei strains showed that type III secretion (TTS) genes were present in all the Ara(-) strains but absent from all but one of the Ara(+) strains. The link between TTS genes and an Ara(-) phenotype suggests a role for TTS in virulence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655407      PMCID: PMC86234     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei.

Authors:  M D Smith; B J Angus; V Wuthiekanun; N J White
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica.

Authors:  M H Yuk; E T Harvill; J F Miller
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

Review 3.  Type III protein secretion systems in bacterial pathogens of animals and plants.

Authors:  C J Hueck
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

4.  Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei.

Authors:  L R Ashdown; J M Koehler
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

5.  Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.

Authors:  P J Brett; D DeShazer; D E Woods
Journal:  Int J Syst Bacteriol       Date:  1998-01

6.  Variation in flagellin genes and proteins of Burkholderia cepacia.

Authors:  B A Hales; J A Morgan; C A Hart; C Winstanley
Journal:  J Bacteriol       Date:  1998-03       Impact factor: 3.490

Review 7.  Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands.

Authors:  J J Mecsas; E J Strauss
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

Review 8.  Melioidosis: review and update.

Authors:  A Leelarasamee; S Bovornkitti
Journal:  Rev Infect Dis       Date:  1989 May-Jun

9.  The hrp gene locus of Pseudomonas solanacearum, which controls the production of a type III secretion system, encodes eight proteins related to components of the bacterial flagellar biogenesis complex.

Authors:  F Van Gijsegem; C Gough; C Zischek; E Niqueux; M Arlat; S Genin; P Barberis; S German; P Castello; C Boucher
Journal:  Mol Microbiol       Date:  1995-03       Impact factor: 3.501

10.  Purification and characterization of a protease from Pseudomonas pseudomallei.

Authors:  M M Sexton; A L Jones; W Chaowagul; D E Woods
Journal:  Can J Microbiol       Date:  1994-11       Impact factor: 2.419

View more
  20 in total

1.  Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei.

Authors:  Ricky L Ulrich; David DeShazer
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes.

Authors:  F M Thibault; E Valade; D R Vidal
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

3.  Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei.

Authors:  Ryan T Novak; Mindy B Glass; Jay E Gee; Daniel Gal; Mark J Mayo; Bart J Currie; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Sensitive and specific molecular detection of Burkholderia pseudomallei, the causative agent of melioidosis, in the soil of tropical northern Australia.

Authors:  Mirjam Kaestli; Mark Mayo; Glenda Harrington; Felicity Watt; Jason Hill; Daniel Gal; Bart J Currie
Journal:  Appl Environ Microbiol       Date:  2007-09-14       Impact factor: 4.792

5.  Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Authors:  Yasmin N Parsons; Stavroula Panagea; Catherine H M Smart; Martin J Walshaw; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Use of a variable amplicon typing scheme reveals considerable variation in the accessory genomes of isolates of Burkholderia pseudomallei.

Authors:  Kwanjit Duangsonk; Daniel Gal; Mark Mayo; C Anthony Hart; Bart J Currie; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  The epidemiology of melioidosis in the Balimo region of Papua New Guinea.

Authors:  J M Warner; D B Pelowa; D Gal; G Rai; M Mayo; B J Currie; B Govan; L F Skerratt; R G Hirst
Journal:  Epidemiol Infect       Date:  2007-08-22       Impact factor: 2.451

8.  Ubiquity of putative type III secretion genes among clinical and environmental Burkholderia pseudomallei isolates in Northern Australia.

Authors:  H C Smith-Vaughan; D Gal; P M Lawrie; C Winstanley; K S Sriprakash; B J Currie
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.

Authors:  Craig Winstanley; Morgan G I Langille; Joanne L Fothergill; Irena Kukavica-Ibrulj; Catherine Paradis-Bleau; François Sanschagrin; Nicholas R Thomson; Geoff L Winsor; Michael A Quail; Nicola Lennard; Alexandra Bignell; Louise Clarke; Kathy Seeger; David Saunders; David Harris; Julian Parkhill; Robert E W Hancock; Fiona S L Brinkman; Roger C Levesque
Journal:  Genome Res       Date:  2008-12-01       Impact factor: 9.043

10.  Type III secretion system genes in clinical Aeromonas isolates.

Authors:  M R Chacón; L Soler; E A Groisman; J Guarro; M J Figueras
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.